Adaptive Biotechnologies
ADPT
ADPT
190 hedge funds and large institutions have $769M invested in Adaptive Biotechnologies in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 59 increasing their positions, 75 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
21% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 75
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
53% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 34
Holders
190
Holding in Top 10
1
Calls
$726K
Puts
$398K
Top Buyers
| 1 | +$31.1M | |
| 2 | +$5.75M | |
| 3 | +$4.46M | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$4M |
| 5 |
DP
DDD Partners
Bellevue,
Washington
|
+$3.39M |
Top Sellers
| 1 | -$6.75M | |
| 2 | -$3.56M | |
| 3 | -$3.35M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$3.11M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.94M |